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The Rho-type GTPase Cdc42p is required for cell polarization and bud emergence in Saccharomyces cerevi-
siae. To identify genes whose functions are linked to CDC42, we screened for (i) multicopy suppressors of a Ts2
cdc42 mutant, (ii) mutants that require multiple copies of CDC42 for survival, and (iii) mutations that display
synthetic lethality with a partial-loss-of-function allele of CDC24, which encodes a guanine nucleotide exchange
factor for Cdc42p. In all three screens, we identified a new gene, BEM4. Cells from which BEM4 was deleted
were inviable at 37&C. These cells became unbudded, large, and round, consistent with a model in which Bem4p
acts together with Cdc42p in polarity establishment and bud emergence. In some strains, the ability of CDC42
to serve as a multicopy suppressor of the Ts2 growth defect of Dbem4 cells required co-overexpression of
Rho1p, which is an essential Rho-type GTPase necessary for cell wall integrity. This finding suggests that
Bem4p also affects Rho1p function. Bem4p displayed two-hybrid interactions with Cdc42p, Rho1p, and two of
the three other known yeast Rho-type GTPases, suggesting that Bem4p can interact with multiple Rho-type
GTPases. Models for the role of Bem4p include that it serves as a chaperone or modulates the interaction of
these GTPases with one or more of their targets or regulators.
During bud emergence in the yeast Saccharomyces cerevisiae,
the actin cytoskeleton becomes polarized toward a discrete
site, where the transport of secretory vesicles is directed for
bud growth (16). CDC42, CDC24, and BEM1 are implicated in
the control of bud emergence: loss-of-function mutations in
any of these genes lead to the loss of actin polarization and can
cause cells to arrest without buds. Because secretion and entry
into the nuclear division cycle are not blocked by these muta-
tions, the mutant cells become large, round, and multinucleate
(1, 3, 11, 13, 26, 47, 48).
Cdc42p is a member of the Rho family of small GTPases
(26). Such GTPases act as molecular switches, through a con-
formational change between their GTP-bound active and
GDP-bound inactive forms. Their nucleotide-bound state is regu-
lated by guanine nucleotide exchange factors (GEFs), GTPase-
activating proteins (GAPs), and guanine nucleotide dissocia-
tion inhibitors (GDIs) (5, 8). Cdc24p displays GEF activity
toward Cdc42p (54). Mutations in CDC24 can be suppressed
by overexpression of CDC42 and display synthetic lethality
with mutations in CDC42 (2, 55), consistent with a model in
which the action of Cdc24p on Cdc42p is important for bud
emergence. Cdc24p has also been linked to the SH3 domain-
containing protein Bem1p. In particular, Cdc24p binds to
Bem1p, and cdc24 and bem1 mutations are synthetically lethal
(38).
In addition to Cdc42p, S. cerevisiae has at least four other
Rho-type GTPases, Rho1p to Rho4p. Rho1p is essential for
viability (33). Cells containing a Ts2 rho1 allele lyse at restric-
tive temperatures, suggesting that Rho1p is required for integ-
rity of the plasma membrane and cell wall (40, 52). One of the
downstream targets of Rho1p is Pkc1p, a protein kinase C
homolog that is required for proper assembly of the cell wall
(31, 32, 37). Rho3p is also important for normal morphogen-
esis (23, 35, 36). At nonpermissive temperatures, cells bearing
Ts2 rho3 alleles fail to polarize actin, are defective in bud
growth, and become large and round. These phenotypes sug-
gest that Rho3p is required for the maintenance of cell polarity
during bud growth (23). RHO2 and RHO4 are not essential,
and cells that lack either one of these genes grow well at all
temperatures (33, 35).
In this paper, we report the discovery of the bud emergence
gene BEM4, whose product appears to be a novel binding
protein for Rho-type GTPases.
MATERIALS AND METHODS
Microbiological techniques. Yeast transformations were performed by the
method of either Ito et al. (25) or Keszenman-Pereyra and Hieda (29). Rich
medium containing glucose (YPD), synthetic minimal medium (SD), and syn-
thetic complete medium (SC) were as described previously (44). SC-Leu is SC
without L-leucine. SDCA contains 0.5% Casamino Acids in SD. SDCA1Ade is
SDCA with 100 mg of adenine sulfate per ml. SDCA-U is SDCA1Ade with 100
mg of tryptophan per ml. SD1Trp1Ade1Lys is SD with 20 mg of L-tryptophan,
40 mg of adenine sulfate, and 30 mg of L-lysine per ml.
DNA manipulations. Standard methods of DNA manipulation were used (44).
The identical nucleotide sequence of BEM4 was determined independently in
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Indiana and in Tokyo by the dideoxy method. Each strand was sequenced
completely, and all sites used for subcloning were sequenced across. Deletion
derivatives of plasmids for sequencing were constructed by the method of Heni-
koff (20), and a model 370A automatic sequencer (Applied Biosystems) was used
for the sequencing done in Tokyo.
Strains and plasmids. Yeast strains used in this study are listed in Table 1.
pBluescript KS1 was purchased from Stratagene (La Jolla, Calif.). YEp24 con-
tains URA3 and the 2mm plasmid replication origin (2mm autonomously repli-
cating sequence [ARS]) (7). The YEp24-based library (10) contains Sau3A
fragments of yeast genomic DNA inserted into the BamHI site of YEp24.
pPB102 (2) and pSRO2-3 (36) are genomic clones containing CDC42 from the
YEp24-based library. pPB320, which contains CDC42, ADE3, LEU2, and 2mm
ARS, was constructed by coinserting a 5-kb BamHI-SalI fragment containing
ADE3 (30) and a 4-kb SalI-EcoRV fragment containing CDC42 from pPB102
into the BamHI-PvuII sites of pSL113 (4). pPB170, which contains CDC24,
ADE3, LEU2, and 2mm ARS, was constructed by inserting a 5-kb XbaI-BamHI
fragment containing CDC24 from plasmid YEp103(CDC24) (14) into the XbaI-
BamHI sites of pPB166 (38). YCp50 contains URA3, CEN4, and ARS1 (42).
pPB527 is a genomic clone containing BEM4 from a YCp50-based library (42).
pGYM50, pGYM149, pGYM241, and pGYM245 are BEM4-bearing isolates
from the YEp24-based library (see Fig. 2). pGYM50-1 was constructed by re-
moving the SalI-SalI fragment from pGYM50. To construct pGYM50-2,
pGYM50 was digested with SmaI and BstXI and then religated after blunting the
BstXI overhang, using the Klenow fragment of DNA polymerase I. pGYM50-3
was constructed by removing the 2.7-kb AflII-AflII fragment of pGYM50.
pGYM50-4 was constructed by inserting the 2.7-kb AflII-AflII fragment from
pGYM50 into the SmaI site of the URA3, 2mm ARS plasmid YEplac195 (17).
pGYM50-5 and pGYM50-7 were made by inserting the 4.8-kb BEM4-bearing
BglII-SalI frag-
ment from pGYM50 into the BamHI-SalI sites of YEplac195 and into the
BamHI-XhoI sites of pBluescript KS1, respectively. To construct pGYM50-6,
pGYM50-5 was digested with AflII and then religated after filling in the four-
base overhang, using Klenow fragment. pSRO4 is an original isolate from the
YEp24-based library (36). YEpSRO4 was made by inserting the 5.5-kb SRO4-
bearing SmaI-SalI fragment into the SmaI-SalI sites of the TRP1, 2mm ARS
plasmid YEplac112 (17). pOPR1 contains the RHO1 coding region under the
control of the TDH3 promoter, TRP1, and 2mm ARS (36). Plasmids used for the
two-hybrid assays are described below. Phage DM1.1.15 was created by inserting
TABLE 1. Strains used in this study
Strain Genotypea Source or reference
GYM5-1 MATa bem4D-1::URA3 ura3 leu2 ade2 his3 trp1 lys2 Segregant from (YPH501 made bem4D-1::URA3 by
gene replacement using pGYM50-8)
GYM5-2 MATa bem4D-1::URA3 ura3 leu2 ade2 his3 trp1 lys2 Same as for GYM5-1
GYM5-11 MATa bem4D-1::HIS3 ura3 leu2 ade2 his3 trp1 lys2 GYM5-1 made ura3::HIS3 (36) by gene replacement
JC24-4 MATa cdc24-4 ura3 leu2 ade2 his3 trp1 lys2 Strain congenic to YPH500 except for the indicated
genotype (derived from a series of crosses involving
YPH500 and Y147 [2])
KA31 MATa/MATa ura3/ura3 leu2/leu2 his3/his3 trp1/trp1 24
PY83 [CDC24, ADE3, LEU2, 2mm ARS] MATa cdc24-4 leu2 ade3 his3 Segregant from (Y49 3 4795-408) transformed with
pPB170
PY88 [CDC24, ADE3, LEU2, 2mm ARS] MATa cdc24-4 ura3 leu2 ade2 ade3 met1 Segregant from (Y108 3 PY83)
PY92 [CDC24, ADE3, LEU2, 2mm ARS] MATa cdc24-4 ura3 leu2 ade2 ade3 met1 Same as for PY88
PY278 [CDC24, ADE3, LEU2, 2mm ARS] MATa cdc24-4 bem1-4 ura3 leu2 ade2
ade3 met1
Sect2 mutant derived from PY88
PY406 [CDC42, ADE3, LEU2, 2mm ARS] MATa ura3 leu2 ade2 ade3 trp1 Y382 containing pPB320
PY407 [CDC42, ADE3, LEU2, 2mm ARS] MATa ura3 leu2 ade2 ade3 lys2 Y388 containing pPB320
PY457 [BEM1, URA3, 2mm ARS] MATa bem1::LEU2 ura3 leu2 trp1 his4 Segregant from (KO2-5 [13] transformed with
pPB321 [3])
PY632 [CDC42, ADE3, LEU2, 2mm ARS] MATa bem1-4 ura3 leu2 ade2 ade3 lys2 Sect2 mutant derived from PY407
PY808 [CDC42, ADE3, LEU2, 2mm ARS] MATa bem4-1 ura3 leu2 ade2 ade3 lys2 Sect2 mutant derived from PY407
PY899 [BEM1, URA3, 2mm ARS] MATa bem1::LEU2 ura3 leu2 ade2 ade3 lys2 Derived from a series of crosses involving Y312,
Y382, Y388, and a segregant from PY457
PY975 [BEM1, URA3, 2mm ARS] MATa bem1::LEU2 ura3 leu2 ade2 ade3 trp1 Segregant from (PY899 3 Y382)
Y49 MATa cdc24-4 his3 met1 Segregant from (PTRD5-BD1-1A [2] 3 DC5 [9])
Y108 MATa cdc24-4 ura3 ade2 ade3 his7 met1 Segregant from (Y49 3 4795-408)
Y253 MATa ura3 leu2 ade2 ade3 his7 trp1 can1 sap3 Segregant from (4795-303 3 4795-408)
Y292 MATa cdc24-4 leu2 his3 GAL2 Segregant from (Y145 [3] 3 DJMD4-30B [26])
Y312 MATa ura3 leu2 his3 GAL2 Segregant from (Y124 [2] 3 Y292)
Y382 MATa ura3 leu2 ade2 ade3 trp1 3
Y388 MATa ura3 leu2 ade2 ade3 lys2 3
Y704 MATa bem4-2 ura3 leu2 ade2 ade3 his7 or HIS7 Segregant from (10.7 3 Y253)
Y799 MATa/MATa ura3/ura3 leu2/leu2 ade2/ade2 ade3/ade3 trp1/trp1 lys2/lys2 Y383 (3) 3 (Y383 made MATa by mating-type inter-
conversion using pGAL-HO [21])
Y833 MATa bem4D-2::URA3 ura3 leu2 ade2 ade3 trp1 lys2 Segregant from (Y799 made bem4D-2::URA3 by gene
replacement using pPB1023)
Y1008 MATa bem1::LEU2 mfa2::pFUS1-lacZ ura3 leu2 ade2 ade3 28
Y1050 MATa ura3:(URA3, OplexA-lacZ) leu2 ade2 his3 trp1 lys2 gal80 L40 (51) made lys2 by growth on 5 a-aminoadipate
(12)
Y1051 MATa bem4-D2::ura3 ura3 leu2 ade2 ade3 trp1 lys2 Y833 made Ura32 on 5-fluoroorotic acid
YMR420 MATa cdc42-1 ura3 leu2 ade2 his3 trp1 lys2 36
YPH500 MATa ura3 leu2 ade2 his3 trp1 lys2 45
YPH501 MATa/MATa ura3/ura3 leu2/leu2 ade2/ade2 his3/his3 trp1/trp1 lys2/lys2 45
10.7 [CDC24, ADE3, LEU2, 2mm ARS] MATa cdc24-4 bem4-3 ura3 leu2 ade2
ade3 met1
Sect2 mutant derived from PY92
11B [CDC42, ADE3, LEU2, 2mm ARS] MATa bem4-2 ura3 leu2 ade2 ade3 lys2 Sect2 mutant derived from PY407
4795-303 MATa leu2 ade2 ade3 trp1 his7 can1 sap3 L. Hartwell
4795-408 MATa ura3 leu2 ade2 ade3 his7 can1 sap3 L. Hartwell
W303 MATa/MATa ura3/ura3 leu2/leu2 ade2/ade2 his3/his3 trp1/trp1 lys2/lys2 50
aMarkers on plasmids are indicated in brackets.
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the 0.4-kb SpeI-NruI fragment from upstream of BEM4 (see Fig. 2 and 3) in
pPB527 into the XbaI-SmaI sites of M13mp19 (53).
Construction of disruption alleles of BEM4. pGYM50-8, which contains
bem4D-1::URA3, was constructed by replacing the 1.1-kb EcoRV fragment (see
Fig. 2 and 3) of pGYM50-7 with the URA3-bearing 1.1-kb SmaI-SmaI fragment
from pJJ242 (27). In bem4D-1::URA3, the sequence between codons 70 and 433
of BEM4 was removed. pPB1023, which contains bem4D-2::URA3, was con-
structed by inserting fragments into pBR322 (6) as follows: (i) the 0.4-kb HincII-
EcoRI fragment from DM1.1.15 (in which the HincII and EcoRI sites are from
the polylinker) was inserted into the SspI-EcoRI sites, (ii) a 0.7-kb HpaI-Sau3A
fragment from the 39 end of BEM4 (see Fig. 2 and 3) from pPB527 was inserted
into the EcoRV-BamHI sites, and (iii) a 1.2-kb HindIII-HindIII fragment con-
taining URA3 from YIpURA3 (S. Lillie, University of Michigan, Ann Arbor) was
inserted into the HindIII site. In bem4D-2::URA3, the DNA between 101 bp
upstream of the start codon and 57 codons upstream of the stop codon of BEM4
was removed. For gene replacements, a 2.6-kb BstXI-PvuII fragment from
pGYM50-8 and a 3-kb PvuI (from within pBR322 sequences)-BamHI (corre-
sponding to the Sau3A site in Fig. 2 and 3) fragment from pPB1023 were used.
In each case, the success of the transplacement into the yeast genome was
confirmed by Southern analysis.
Isolation of multicopy suppressors of the cdc42 defect. Ts2 cdc42-1 strain
YMR420 containing YEpSRO4 was transformed with the YEp24-based genomic
library and plated on SDCA1Ade plates. After incubation at 258C for 1 day
followed by incubation at 378C for 3 days, cells that could form visible colonies
were isolated and cultured in SDCA1Ade. To confirm the ability of the plasmids
to suppress the cdc42 Ts2 growth defect, each plasmid was reintroduced at 258C
into YMR420 containing YEpSRO4. Transformants were streaked on SDCA1
Ade plates and incubated at 378C for 2 days. Plasmids that carried CDC42 were
identified by amplification of a 740-bp DNA fragment, using PCR (43) with the
two convergent primers 59-AAAAAAAGATCTTCCACAAAATGCAAA and
59-GGGGGGGTCGACGGATGATCCTGGCGC (underlined sequences indi-
cate extensions that were introduced to allow for more efficient restriction of the
amplified fragment).
Colony-sectoring assays.A previously described colony-sectoring assay (3) was
used to identify mutants that required multiple copies of CDC42 for survival.
This assay is based on the facts that ade2 mutants are red, ade2 ade3 mutants are
white, and 2mm ARS-based plasmids typically are segregated imperfectly be-
tween mother cell and daughter cell. Thus, when grown on YPD (nonselective)
medium, ade2 ade3 cells that contain the CDC42- and ADE3-bearing plasmid
pPB320 form colonies that contain red and white sectors (Sect1 phenotype),
derived from cells that had retained and those that had lost the plasmid, respec-
tively. However, in mutants that need multiple copies of CDC42 for survival, only
those cells that inherit the plasmid can proliferate, resulting in uniformly red
colonies (Sect2 phenotype). To search for mutants, strains PY406 and PY407
were plated on YPD and mutagenized with UV irradiation to approximately
10% survival, and Sect2 colonies were isolated. To test for dominance of the
Sect2 phenotype, mutants were crossed to Y382 or Y388. To test whether
mutants required CDC42 itself (as opposed to some other gene on the plasmid,
such as ADE3), representative members of each complementation group were
transformed separately with the CDC42-bearing plasmid pPB102 and with the
control plasmid YEp24 (selecting for Ura1 transformants). Those mutants that
became Sect1 when transformed with pPB102 and remained Sect2 when trans-
formed with YEp24 were judged to be CDC42 requiring. Representative mem-
bers of each group were then mated to known Ts2 cdc42 and cdc24mutants. The
resulting diploids were cured of the plasmid at room temperature and then tested
for the ability to grow at 378C.
To identify mutations that display synthetic lethality with cdc24, we used
essentially the procedure just described, except that the cdc24-4 strains PY88 and
PY92 (containing the CDC24- and ADE3-bearing plasmid pPB170) were used.
To test whether the Sect2 mutants required CDC24 itself from plasmid pPB170
for survival, we assayed the sectoring abilities of mutants after transformation
with YEp103(CDC24) or with YEp24.
Isolation of multicopy suppressors of the Dbem4 defect. bem4D-1::HIS3 strain
GYM5-11 was transformed with the YEp24-based library and plated on SDCA-
U plates. After incubation at 378C for 4 to 6 days, cells from visible colonies were
isolated and cultured in SDCA-U. Plasmids were recovered and reintroduced
into GYM5-11 to confirm the ability to suppress the bem4 Ts2 phenotype.
Suppressing plasmids were classified by restriction analysis. Plasmids containing
MSB1 (3) were identified by PCR using the following two sets of convergent
primers, which were designed to amplify two distinct regions in MSB1: (i) 59-
AGTATGGATGACGAAGAG and 59-TTTTAAGCTTTTCGGATGTTTG
and (ii) 59-GAATGTATTGAGGTTAA and 59-GTATTTGTACTAAGCTTC
AATGA (underlined residues indicate substitutions that were introduced to
create sites for restriction). Plasmids pMSB1 and pMSB4, which were isolated
from this screen, carried MSB1. pMSB4D, bearing a disrupted MSB1 coding
region, was made by removing a BglII-BglII fragment from pMSB4.
Two-hybrid analysis. The DBD (DNA-binding domain of LexA) fusions were
constructed in pEG202 (15, 18). (These DBD fusion plasmids were kindly pro-
vided by C. De Virgilio, The University of North Carolina.) In the DBD fusion
proteins, the Cys of the CAAX box (plus the adjacent Cys in Rho2p) of each
GTPase was mutated to Ser to prevent prenylation (15, 56). pACTII contains the
AD (transcriptional activation domain) of GAL4, LEU2, and 2mm ARS (19).
pPB725 contains the AD of GAL4 fused to the third codon of BEM4 in pACTII.
pPB725 was constructed by first introducing a BamHI site at the third codon of
BEM4 by site-directed mutagenesis using the oligonucleotide TTTCTTCGG
GATCCATTTAG and then inserting a 2.5-kb BamHI-Sau3AI fragment con-
taining BEM4 into the BamHI site of a version of pACTII in which the NcoI site
had been filled in with Klenow fragment. pACTII and pPB725 were introduced
separately into Y1050, selecting for transformants on SC-Leu. The plasmids that
encode the DBD fusions were introduced into the resulting pACTII- and
pPB725-bearing strains, selecting for transformants on SD1Trp1Ade1Lys.
Overnight liquid cultures were diluted 40-fold in SC1Trp1Ade1Lys and grown
for 8 h with shaking at 308C to an optical density at 600 nm of 0.1 to 0.5.
b-Galactosidase assays were performed as described previously (41). Four inde-
pendent transformants were tested for each combination of plasmids.
Morphological observations. Cells were stained with 49,69-diamidino-2-phe-
nylindole (DAPI) to reveal DNA and with rhodamine-phalloidin to reveal actin
filaments as described previously (39). Cells were fixed with 5% formaldehyde for
10 min, washed with phosphate-buffered saline (PBS; 140 mM NaCl, 2.7 mM
KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4 [pH 7.3]), and then stained with a
1:50-diluted solution of rhodamine-phalloidin (Molecular Probes, Eugene,
Oreg.) for 2 h, and DAPI was added to a final concentration of 125 ng/ml. The
cells were washed five times with PBS. These samples were mounted in 10 mg of
n-propyl-gallate per ml in 90% glycerol and observed with an epifluorophotomi-
croscope (Olympus BH-2).
Nucleotide sequence accession number. The sequence shown in Fig. 3 is
available from EMBL/GenBank/DDBJ under accession number L27816.
RESULTS
Isolation of multicopy suppressors of cdc42. SRO4, which
was identified originally as a multicopy suppressor of rho3 (36),
can serve as a weak multicopy suppressor of the growth defect
of a cdc42-1mutant at 34.58C but fails to do so at 378C (Fig. 1).
To identify other genes whose functions are linked to Cdc42p,
we screened for plasmids from a YEp24-based yeast genomic
library that, in combination with a high-copy-number SRO4-
bearing plasmid, would allow suppression of a cdc42-1 mutant
at 378C. Seventy-eight plasmids were isolated in this screen.
PCR analysis revealed that 74 of these contained CDC42.
Restriction analysis indicated that the remaining plasmids,
pGYM50, pGYM149, pGYM241, and pGYM245, harbored
inserts derived from a single other genomic locus (Fig. 2).
Although the ability of these plasmids to suppress cdc42 effec-
tively at 378C required co-overexpression of SRO4, each plas-
mid was sufficient for suppression at 34.58C (Fig. 1).
The suppressing activity was mapped to a 4.8-kb BglII-SalI
segment (Fig. 2). The insertion of 4 bp (by using Klenow
fragment) at the unique AflII site within this segment (in
pGYM50-6) destroyed the suppressing activity. Sequence anal-
ysis of a 3.2-kb fragment of DNA from this region revealed that
the AflII site is located within a large open reading frame for
a new gene, which we call BEM4 (Fig. 3). The sequence of the
inferred Bem4 protein is 633 amino acids long (Fig. 3). It is not
similar to the sequence of any other known protein and con-
tains no obvious motifs.
FIG. 1. Suppression of cdc42. Cells of cdc42-1 strain YMR420 containing the
vectors YEp24 plus YEplac112 (A), YEp24 plus YEpSRO4 (a high-copy-num-
ber plasmid carrying SRO4) (B), pGYM50 (a high-copy-number plasmid carry-
ing BEM4) plus YEplac112 (C), and pGYM50 plus YEpSRO4 (D) were
streaked on SDCA1Ade plates and incubated at the indicated temperatures for
2 days.
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Disruption of BEM4. To investigate the function of BEM4,
we deleted it from the MATa/MATa diploid strain YPH501
(see Materials and Methods). Segregants deleted for BEM4
were viable at 308C but inviable at 378C. When an exponen-
tially growing culture of Dbem4 strain GYM5-1 was shifted
from 30 to 378C, cells began to stop dividing after approxi-
mately 5 h (data not shown). Eight hours after the shift, ap-
proximately 80% of the cells were unbudded, round, and large
(Fig. 4). Approximately 20% of all cells contained two nuclei.
These phenotypes are similar to those caused by loss of Cdc42p
function (1). Although the distribution of actin appeared nor-
mal at 308C (Fig. 4A), actin patches were distributed through-
out the cell cortex at 378C (Fig. 4B).
Identification of CDC42 multicopy-suppressee mutants.
Mutants that require multiple copies of CDC42 for survival
were sought from strains PY406 and PY407, which contain the
CDC42- and ADE3-bearing plasmid pPB320, using a colony-
sectoring assay (see Materials and Methods). In this assay, a
mutant that requires multiple copies of CDC42 for survival
forms uniformly red colonies that lack white sectors (Sect2
phenotype). We imagined that different mutations might be
suppressed by CDC42 at different temperatures, and so we
searched for CDC42-requiring mutants at 30, 34, and 378C.
Prior experience (3) suggested that the Sect2 phenotype of
most or all of the dominant Sect2 mutants would be due to
integration of pPB320 into the genome. Therefore, we did not
pursue any dominant Sect2 mutants.
Among the remaining mutants, we identified four comple-
mentation groups that required specifically CDC42, as opposed
to ADE3 or LEU2, from pPB320 for survival (see Materials
and Methods) (Table 2). By a combination of complementa-
tion and plasmid-based suppression tests, the group I and
group II mutants were deduced to be defective in CDC42 and
CDC24, respectively. The isolation of mutations in CDC42 and
CDC24 was expected because CDC42 is essential for viability
(26) and CDC42 was previously isolated as a multicopy sup-
pressor of cdc24 (2). The following results suggest that strain
PY632, the sole member of group III, is defective in BEM1.
First, the diploid formed by crossing PY632 to bem1::LEU2
strain PY975, when cured of plasmid at 238C, was unable to
grow at 378C. Second, when transformed with a low-copy-
number plasmid bearing BEM1, PY632 became Sect1. The
growth defects of the bem1::LEU2 strain Y1008 at 358C could
be partially suppressed by overexpression of CDC42 (from
plasmid pPB102), demonstrating that CDC42 can indeed serve
as a multicopy suppressor of bem1.
From the results of complementation and plasmid-based
suppression tests, we concluded that the group IV mutants
were not defective in any of the known bud emergence genes
CDC24, CDC42, CDC43, BEM1, or BEM2 (data not shown).
Members of this group, although Sect2 at 308C or higher
temperatures, were Sect1 at 238C. From the YCp50-based
genomic library, we isolated a plasmid that could suppress both
the Sect2 phenotype of group IV mutant PY808 at 308C and
the growth phenotype of the same strain at 378C (after loss of
pPB320 at 238C). A 2.6-kb NruI-Sau3A segment of the insert
from this plasmid (Fig. 2 and 3) was sufficient for the suppres-
sion of both the Ts2 growth defect and the Sect2 phenotype.
A 3.2-kb segment of DNA that encompasses this suppressing
region was sequenced and found to contain BEM4 (Fig. 2 and
3). Dbem4 strain Y1051, which grows only poorly at 308C and
is inviable at 338C, could grow well at temperatures up to 378C
when transformed with the high-copy-number, CDC42-bearing
plasmid pPB320 (data not shown), indicating that the Ts2
FIG. 2. Subcloning of BEM4. The inserts of the isolated BEM4 clones and subclones, and the Dbem4 disruption alleles, are diagrammed below the restriction map
of the BEM4 region. 1 and 2 indicate growth and lack of growth of transformants (in YEpSRO4-bearing strain YMR420) after incubation for 3 days at 378C. The
coding region of BEM4 is represented by an open arrow. Shadowed arrows represent the coding region of URA3. The open box indicates the fragment used as a probe
for physical mapping. The small arrowhead represents the AflII site at which 4 bp were inserted into pGYM50-6. All A (AflII), B (BstXI), E (EcoRI), G (BglII), P
(PvuII), S (SalI), and V (EcoRV) and some H (HpaI), N (NruI), Sa (Sau3AI), and Sp (SpeI) sites are shown.
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growth defect of bem4 mutants can indeed be suppressed by
overexpression of CDC42. However, for reasons that are not
yet clear, high-copy-number CDC42 was not sufficient for sup-
pression of the Dbem4 growth defect in the unrelated strain
GYM5-11 (see Fig. 5C; discussed below).
Although mutations in CDC42 and CDC24 were isolated
from screens using both PY406 and PY407, all 32 of the bem4
mutants were derived from PY407 (and none were derived
from PY406), suggesting that PY407 may contain one or more
other mutations that are required for the Sect2 phenotype of
bem4 cells. In crosses between each of two group IV (bem4
Sect2 Ts2) mutants and Y382 (BEM4 Sect1 Ts1), the Ts2:
Ts1 phenotype segregated 2:2, confirming that loss of BEM4
function is sufficient for the Ts2 phenotype at 378C. However,
only approximately half of the Ts2 segregants, and none of the
Ts1 segregants, were Sect2 at 308C (Table 3), suggesting that
a single other mutation is required for the Sect2 phenotype of
bem4 mutants. We have not yet identified this second muta-
tion.
Identification of mutations that display synthetic lethality
with cdc24. Cells carrying the cdc24-4 mutation, although un-
able to grow at 378C, can grow well at 308C. To search for
mutations that displayed synthetic lethality with cdc24, we used
a colony-sectoring assay to screen for mutations that caused
cdc24-4 strains PY88 and PY92 to require CDC24 (on the
ADE3-bearing plasmid pPB170) for survival at 308C. From this
screen, 161 recessive Sect2 mutants were isolated. From the
results of complementation and linkage analyses, we deter-
mined that 159 of these mutants were likely to be defective in
CDC24. These mutants were not studied further. One of the
two remaining Sect2 mutants, PY278, was judged to be defec-
tive in BEM1 because (i) a BEM1-containing, low-copy-num-
ber plasmid was able to suppress its Sect2 phenotype and (ii)
the diploid created by crossing it to bem1::LEU2 strain PY899,
when cured of plasmid at 238C, was unable to grow at 378C.
The single remaining Sect2 mutant that was identified from
this screen is strain 10.7. From the results of tetrad analysis, we
judged that the Sect2 phenotype of 10.7 was due to a synthetic-
lethal interaction between cdc24-4 and a second mutation that,
by itself, also gave a Ts2 growth phenotype (data not shown).
A single plasmid that could suppress the Ts2 phenotype was
isolated from the YCp50-based genomic library. Restriction
analysis indicated that this plasmid contained BEM4. More-
over, the diploid strain formed by crossing Y704 (a derivative
of 10.7, cured of plasmid) to bem4D-2::URA3 strain Y833 was
unable to grow at 378C, strongly suggesting that Y704 does in-
deed contain a mutation in BEM4. In a cross between bem4D-1::
URA3 strain GYM5-2 and cdc24-4 strain JC24-4, although
both the cdc24-4 BEM4 and CDC24 bem4D-1::URA3 seg-
regants grew well at 328C, the bem4D-1::URA3 cdc24-4 seg-
regants were inviable at this temperature (data not shown),
confirming that cdc24-4 is synthetically lethal with bem4.
Two-hybrid interactions involvingBem4pandRho-typeGTP-
ases. Cdc42p displays a two-hybrid interaction with Bem4p
(Table 4). Combined with the multicopy suppressor and multi-
copy suppressee relationships between BEM4 and CDC42, this
two-hybrid interaction suggests that Cdc42p binds to Bem4p
during the normal functions of these proteins. Cdc42pG12V and
FIG. 3. Nucleotide and deduced amino acid sequences of BEM4. The following sites are indicated with boldface letters: SpeI (175), NruI (575), EcoRV (877), AflII
(1326), EcoRV (1963), HpaI (2394), and Sau3A (3133).
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Cdc42pQ61L are mutant versions of Cdc42p that are predicted
to exist predominantly in the GTP-bound state. Cdc42pD118A is
a mutant version of Cdc42p that gives a dominant negative
phenotype and is predicted to have a conformation similar to
that of the GDP-bound, inactive form (55, 56). All three of
these mutant versions of Cdc42p displayed comparable two-
hybrid interactions with Bem4p, suggesting that Bem4p can
interact with both the active and inactive forms of Cdc42p.
Bem4p also displays two-hybrid interactions with Rho1p,
Rho2p, and Rho4p (Table 4), suggesting that Bem4p binds to
multiple Rho-type GTPases. However, we failed to detect two-
hybrid interactions between Bem4p and either Rho3p (Table
4) or the Ras-type GTPase Ras2p (15a).
Genetic interactions between BEM4 and RHO1. The two-
hybrid interaction between Bem4p and Rho1p suggests that
these two proteins may interact functionally with each other.
To explore this possibility, we examined whether RHO1 could
serve as a multicopy suppressor of the Ts2 growth defect
caused by deletion of BEM4. To do so, we exploited the finding
that overexpression of CDC42 was not sufficient for suppres-
sion of the growth defect of Dbem4 strain GYM5-11 at 378C
(Fig. 5C). Overexpression of RHO1 alone was also insufficient
for suppression at 378C (Fig. 5B). However, co-overexpression
of RHO1 and CDC42 effected strong suppression (Fig. 5D),
suggesting that Bem4p does indeed play a role in the function
of Rho1p in addition to its putative role in the function of
Cdc42p.
Identification of multicopy suppressors of bem4. To investi-
gate further the function of Bem4p, we screened for multicopy
suppressors of the Ts2 growth defect of a Dbem4mutant. From
a high-copy-number yeast genomic library, we identified 11
plasmids that enabled GYM5-11 cells to grow well at 378C (see
Materials and Methods). The results of restriction analysis
indicated that two of these plasmids carry BEM4 itself and the
other nine contain DNA from four other loci (data not shown).
From restriction and PCR analysis (see Materials and Meth-
ods), we determined that one of these loci contained MSB1
(data not shown), a gene that was shown previously to be a
multicopy suppressor of both cdc24 and cdc42 in sorbitol-
containing medium (2) and to display synthetic-lethal interac-
tions with bem1 and bem2 (3). Deletion of a 0.5-kb BglII-BglII
fragment from within the MSB1 open reading frame of the
isolated plasmid eliminated its ability to suppress the Ts2
growth defect of GYM5-11, indicating that the relevant gene in
this insert is indeed MSB1 (data not shown). The character-
ization of the three remaining multicopy suppressors of bem4,
which we call SBE1-3, will be presented elsewhere.
DISCUSSION
The goal of this study was to identify genes whose functions
are linked to that of Cdc42p. We discovered BEM4 from
screens for (i) multicopy suppressors of cdc42, (ii) mutations
FIG. 4. Phenotypes of Dbem4 mutants. A culture of bem4D-1::URA3 strain
GYM5-1 that was growing exponentially at 308C was split in two; one culture was
kept at 308C, and the other was grown at 378C. Cultures were harvested after 8 h
at 308C (A) or 378C (B and C) and stained with rhodamine-phalloidin to reveal
actin (A and B) and with DAPI to reveal DNA (C). The bar represents 5 mm.
TABLE 2. CDC42-requiring mutants isolated at
different temperaturesa
Temp (8C)
No. of mutants in complementation group (gene):
I (CDC42) II (CDC24) III (BEM1) IV (BEM4)
30 38 9 1 12
34 83 3 0 17
37 14 0 0 3
a Sect2 mutants were isolated from strains PY406 and PY407 and analyzed as
described in Materials and Methods.
TABLE 3. Segregation patterns of the Sect2 and Ts2





Sect1b Sect2 Sect1 Sect2
PY808 (bem4-1) 3 Y382 (BEM4) 24 0 14 10
11B (bem4-2) 3 Y382 (BEM4) 22 0 11 6
a Growth at 378C was assayed after cells were cured of plasmid at 238C.
b The sectoring phenotype was assayed at 308C.
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that required multiple copies of CDC42 for survival, and (iii)
mutations that displayed synthetic lethality with a mutant allele
of CDC24. The only other genes that were isolated from these
screens were CDC24 (from the second screen) and BEM1
(from the second and third screens), suggesting that these
screens were indeed selective for genes whose functions are
tightly linked to that of Cdc42p. At high temperatures, deletion
of BEM4 can cause cells to become unbudded, round, large,
and multinucleate, consistent with the view that Bem4p func-
tions with Cdc42p in bud emergence.
Suppression of the Ts2 growth defect of Dbem4 strain
GYM5-1 required co-overexpression of RHO1 and CDC42,
suggesting that Bem4p also plays a role in Rho1p function.
MSB1, which can serve as a multicopy suppressor of the Ts2
growth defect of Dbem4 cells, can also serve as a multicopy
suppressor of the Ts2 growth phenotypes of both cdc42 (3) and
rho1 (40a) mutants, consistent with a model in which Bem4p
promotes the actions of both Cdc42p and Rho1p. Strong sup-
port for the idea that Bem4p promotes the action of Rho1p
comes from the recent isolation of BEM4 as a multicopy sup-
pressor of the growth defect caused by a dominant negative
allele of rho1 (22). Additional support for this view is the
finding that SBE1, which we isolated as a multicopy suppressor
of the Ts2 growth defect of the Dbem4 mutant GYM5-1, maps
to the same locus (adjacent to PHO85 on chromosome XVI
[36a]) that was identified recently as a multicopy suppressor of
rho1 (40a).
The phenotypes caused by deletion of BEM4 varied with
genetic background. For example, the restrictive temperatures
for growth caused by deletion of BEM4 were different for
different strains. Also, although deletion of BEM4 from some
strains (e.g., YPH501 [Fig. 4], W303, and KA31 [data not
shown]) caused cells to become unbudded, large, round, and
multinucleate at 378C, its deletion from other strains (e.g.,
Y799) did not cause such obvious bud emergence defects.
Instead, Dbem4 cells derived from Y799 became misshapen
and lysed at 378C (32a). We have observed similar effects with
BEM1 and BEM2, whose products are also linked to the func-
tions of Rho-type GTPases; in some strains, the deletion of
either gene leads to a bud emergence defect, whereas in other
strains, these deletions result in misshapen cells that lyse at
high temperatures. In addition, the restrictive temperature for
deletion of either BEM1 or BEM2 can vary from one strain to
another (1a). We have not yet identified the background mu-
tations that affect the phenotypes of strains deleted for the
BEM genes.
Because genetic and two-hybrid interactions suggest that
Bem4p can affect the functions of both Cdc42p and Rho1p, it
is possible that the phenotypic variation of different Dbem4
strains is due to one or more background mutations that affect
the functions of one or the other or both of these GTPases.
The Ts2 growth defect of Dbem4 strain Y1051 can be effi-
ciently suppressed by overexpression of CDC42 alone, suggest-
ing that this strain may be relatively insensitive to the Dbem4
effects on Rho1p function. In contrast, the finding that co-
overexpression of CDC42 and RHO1 is required for suppres-
sion of the Ts2 growth defect of Dbem4 strain GYM5-1 sug-
gests that this strain may have one or more mutations that
make it particularly sensitive to impaired Rho1p function.
Bem4p displays two-hybrid interactions with Cdc42p, Rho1p,
Rho2p, and Rho4p. These GTPases are not so similar in se-
quence to one another that any protein that displays a two-
hybrid interaction with one will inevitably interact with the
others; various other proteins that display two-hybrid interac-
tions with Cdc42p (e.g., Cla4p, Ste20p, Bem3p, and Rga1p)
failed to display two-hybrid interactions with Rho1p-Rho4p
(15, 46, 49). Thus, these GTPases can be discriminated from
one another in two-hybrid assays. The genetic interactions
between Bem4p and both Cdc42p and Rho1p support the view
that Bem4p binds to Cdc42p and Rho1p during normal func-
tion in vivo. In this context, it is likely that the two-hybrid
interactions between Bem4p and both Rho2p and Rho4p also
reflect interactions that occur in vivo.
The ability of Bem4p to display two-hybrid interactions with
wild-type Cdc42p, Cdc42pG12V, Cdc42pQ61L, and Cdc42pD118A
(Table 4) suggests that Bem4p can bind to both the active and
inactive forms of Cdc42p. Of the proteins known to bind to
Rho-type GTPases (e.g., GDIs, GEFs, GAPs, and effectors),
only Rho GDIs can bind to both the GDP- and GTP-bound
states of multiple Rho-type GTPases, raising the possibility
that Bem4p itself may serve one or more roles associated with
Rho GDI. Some support for this possibility is the observation
that although RDI1, which encodes a yeast Rho GDI, normally
can be deleted without obvious effect on cell growth (34), RDI1
becomes essential, or nearly so, in cells that lack BEM4 (34a).
However, Rdi1p appears to account for all of the Rho GDI
activity in yeast strains (34). Furthermore, Bem4p is not similar
in sequence to known Rho GDIs, and RDI1 cannot serve as a
FIG. 5. Suppression of Dbem4. Cells of bem4D-1::URA3 strain GYM5-11 con-
taining the vectors YEp24 plus YEplac112 (A), YEp24 plus pOPR1 (a high-
copy-number plasmid carrying RHO1 under the control of the TDH3 promoter)
(B), pSRO2-3 (a high-copy-number plasmid carrying CDC42) plus YEplac112
(C), and pSRO2-3 plus pOPR1 (D) were streaked on YPD plates and incubated
at 378C for 2 days.





— 0.09 6 0.08 0.17 6 0.08
Cdc42C1885 2.2 6 0.6 280 6 20
Cdc42G12V,C188S 9.5 6 1.4 270 6 30
Cdc42Q61L,C188S 10 6 3 250 6 60
Cdc42D118A,C188S 0.13 6 0.03 380 6 60
Rho1C206S 0.08 6 0.03 99 6 34
Rho2C188S/C189S 0.15 6 0.01 66 6 18
Rho3C228S 0.08 6 0.03 0.14 6 0.07
Rho4C188S 0.12 6 0.02 330 6 70
a The DBD fusions were all expressed from derivatives of pEG202 (see Ma-
terials and Methods). —, unfused DBD.
bMean 6 the standard deviation derived from four independent transfor-
mants.
c Unfused AD of Gal4p, encoded by pACTII.
d Encoded by pPB725.
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multicopy suppressor of Dbem4 (34a). Thus, although Bem4p
may have a function related to that of Rho GDI, we think that
Bem4p itself is unlikely to be a Rho GDI. Other potential roles
for Bem4p include promoting the folding, stability, or localiza-
tion of multiple Rho-type GTPases or regulating the binding of
these GTPases to their targets or regulatory proteins (e.g.,
GEFs, GAPs, GDIs, processing proteins, or degradation ma-
chinery).
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